Abstract
Phagocytosis and killing activities of alveolar macrophages were compared in 17 patients with stage 1 sarcoidosis and 6 healthy controls. The average total cell count of bronchoalveolar lavage fluid from patients with sarcoidosis was 7.8 ± 7.5 × 106 cells; 70.4 ± 15% of these cells were alveolar macrophages and 25.9 ± 16.2% lymphocytes. Average total cell count from controls was 8.33 ± 8.6 × 106 cells, with 92.7 ± 5.9% alveolar macrophages and 6.6 ± 4.4% lymphocytes. Purified alveolar macrophages were tested in in vitro antibacterial assays using S. aureus as a test microbe. Moderate decreases in the kinetics of staphylococcal ingestion were detected in the sarcoidosis group. The intracellular killing activity of macrophages was much lower in the patients with sarcoid than in control subjects. In a pilot study, intracellular killing activity of macrophages from 1 patient: with sarcoidosis was greatly enhanced by 24 hr treatment with transfer factor. In summary, alveolar macrophages from patients with radiographic stage 1 sarcoidosis have decreased bacterial ingestion and intracellular killing activities. These results suggest that macrophages undergo complex functional changes in sarcoidosis that may influence both disease development and host defenses.
Similar content being viewed by others
References
Al-Ibrahim MS, Valentine FT, Lawrence HS (1978) Activated lymphocytes depress phagocytosis of latex particles by human monocyte-macrophages. Cell Immunol 41:217–230
Ashorn R, Seppala E, Karhumaki E, Vapaatalo H, Krohn K (1983) Porcine spleen cell dialysate increases the phagocytic capacity and decreases prostaglandin levels of peritoneal macrophages in mouse. In: Kirkpatrick CH (ed) Immunbiology of transfer factor. Academic Press, New York, pp 365–375
Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298:659–721
Catanzaro A, Spitler L (1976) Transfer factor in diseases of the lung. In: Kirpatrick HC, Reynolds HY (eds) Immunologic and infectious reactions in the lung. Marcel Dekker, New York, pp 519–549
Cherniack RM (1990) Bronchoalveolar lavage. Am Rev Respir Dis 141:S169-S206
Clavel F, Laval A, Venet A, Cayrol E, Chretien J (1987) Alveolar macrophage phagocytosis in sarcoidosis. Ann NY Acad Sci 498:110–121
Daniele RP (1985) Immunology of sarcoidosis. In: Kay AB, Svetzl EJ (eds) Current perspectives in the immunology of respiratory diseases. Edinburgh, Churchill Livingstone, pp 7–99
James GD, Williams WJ (1985) Sarcoidosis and other granulomatous disorders. WB Saunders, Philadelphia, pp 174–199
Johnston RB (1988) Current concepts: immunology, monocytes and macrophages. N Engl J Med 318:747–752
Kataria YP (1985) Immunology of sarcoidosis. In: Lieberman J (ed) Sarcoidosis. Grune and Stratton, Orlando, FL, pp 39–65
Kirkpatrick HC (1988) Transfer factor. J Allergy Clin Immunol 81:803–813
Lawrence HS (1955) The transfer factor in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes. J Clin Invest 34:219–232
Mackaness GB (1970) The mechanisms of macrophage activation. In: Mudd S (ed) Infectious agents and host reactions. WB Saunders, Philadelphia, pp 2–67
Nathan CF, Terry WD (1978) Decreased phagocytosis by peritoneal macrophages from BCG-treated mice. Cell Immunol 29:295–311
Martin RR, Lawrence EC, Teague RS, Gottlieb MS, Putman M (1986) Chemiluminescence of lung macrophages and blood leukocytes of sarcoidosis. Am Rev Respir Dis 133:298–301
Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J. Lab Clin Med 84:559–573
Schroder I (1982) Zur preparation, characterisierung und immunotherapeutischen erprobung von transfer factor. Rostock, Wilhelm-Pick-Universitat, thesis.
Schroder I, Luneburg S (1984) ‘Transfer factor—a lymphocyte cell surface component’. Allerg Immunopathol 12:1–22
Semenzato G, Chilosi M, Ossi E, Trentin L, Pizzolo G, Cipriani A, Agostini C, Zambello R, Marcer G, Gasparatto G (1985) Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis 132:400–404
Swenson FJ, Kozel RT (1978) Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages. Infect Immun 21:714–720
Thomas PD, Hunninghake GW (1987) Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 135:747–760
Valenti S, Scordamaglia A, Crimi P, Mereu C (1962) Bronchoalveolar lavage and transbronchial lung biopsy in sarcoidosis and extrinsic allergic alveolitis. Eur J Respir Dis 63:564–569
Van Furth R, van Zwet Th L, Leijh PCJ (1978) In vitro determination of phagocytosis and intracellular killing in polymorphonuclear and mononuclear phagocytes. In: Weir DM (ed) Handbook of experimental immunology. Blackwell Scientific Publications, Oxford, chap 32, pp 1–18
Vezendi S, Sonkoly I, Mandi L, Kavai M, Shroder I (1982) Immunologic aspects of sarcoidosis, attempted therapy with transfer factor and levamisol. 3rd European Conference on sarcoidosis and other granulomatous disorders. Duric B (ed) Novi-Sad, pp 504–516
Author information
Authors and Affiliations
Additional information
Offprint requests to: P. Orosi
Rights and permissions
About this article
Cite this article
Orosi, P., Nugent, K. Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis. Lung 171, 225–233 (1993). https://doi.org/10.1007/BF00203722
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00203722